a human antibody given to monkeys infected with the deadly hendra virus completely protected them from disease, according to a study published by national institutes of health (nih) scientists and their collaborators. hendra and the closely related nipah virus, both rare viruses that are part of the nih biodefense research program, target the lungs and brain and have human case 1 rates of 60 percent and more than 75 percent, respectively. these diseases in monkeys mirror what happens in humans, and the study results are cause for hope that the antibody, named m102.4, ultimately may be developed into a possible treatment for people who become infected with these viruses. in may 2010, shortly after the nih study in monkeys successfully concluded, australian health officials requested m102.4 for emergency use in a woman and her 12-year-old daughter. they had been exposed to hendra virus from an ill horse that ultimately was euthanized（安乐死） . both the woman and child survived and showed no side effects from the treatment.
"this is an important research advance that 2 how scientific discoveries emerge through a steady stepwise（逐步地） process, and how our investment in research on countermeasures for biodefense and emerging infectious diseases can help global preparedness efforts," said anthony s. fauci, m.d., director of the nih's national institute of 3 and infectious diseases (niaid).
hendra virus emerged in 1994 in australia and primarily affects horses, which can spread the disease to humans. no person-to-person transmission of hendra has been reported. nipah virus emerged in 1998 in malaysia, and also has been found in bangladesh and india. nipah appears to infect humans more easily than hendra and can be transmitted from person to person.
the niaid-supported study, which appears online in science translational medicine, involved infecting 14 african green monkeys with a 4 dose of hendra virus. twelve of the monkeys then received two treatments with m102.4, one either at 10, 24, or 72 hours after being infected, and another 48 hours later. all 12 monkeys treated with the antibody survived. the two untreated control monkeys died eight days after being infected.
the findings are the result of a series of studies carried out by different research laboratories. a group from nih's national cancer institute and the uniformed services university of the health sciences (usuhs) discovered m102.4 in 2006 and developed the antibody for use in laboratory research. usuhs and australian collaborators then developed an animal study model of m102.4 in ferrets（雪貂） infected with nipah virus; the university of texas medical branch and usuhs developed a monkey study model of hendra and nipah infection; and together with 5 from boston university and niaid's rocky mountain laboratories (rml) designed and carried out the antibody trial in biosafety level-4 (bsl-4) laboratory space at rml. because the hendra and nipah viruses are so deadly and there is no 6 7 or treatment for either of them, both viruses must be studied in maximum-containment bsl-4 laboratories.
收听单词发音 
